Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of HY-1608 injection for postoperative analgesia after abdominal surgery
CTR20252836Phase 2Active
- Sponsor
- Beijing Junke Huayuan Pharmaceutical Technology
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HY-1608 in postoperative pain, sponsored by Beijing Junke Huayuan Pharmaceutical Technology. Started Aug 2025; status: active.
02
Drugs
HY-1608
03
Conditions
postoperative pain
Beyond the preview
Go deeper on CTR20252836.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20252836.